{"changes":[{"companyHref":"/c/tinostherapeutics-com","date":"2026-09-25","documentUrl":null,"domain":"tinostherapeutics.com","fact":"latest round","name":"Tinos Therapeutics, Inc.","new":{"amountUsd":2300000,"date":"2025-09-04","lead":null,"type":null},"old":{"amountUsd":2300000,"date":"2025-09-04","lead":null,"type":"seed"},"publisher":"sec-edgar","reason":null,"retrievedAt":"2026-05-08","slug":"tinostherapeutics-com","status":"attributed","url":"https://whoraisedwhat.com/c/tinostherapeutics-com"}],"country":"US","description":"Tinos Therapeutics is a clinical-stage biotech developing oral small-molecule drugs for solid-tumor oncology. It serves cancer patients and pharma partners pursuing kinase-targeted therapies for resistant cancers. Its lead compound targets a kinase undruggable by previously approved agents, an opening big-pharma kinase programs have largely written off.","domain":"tinostherapeutics.com","employees":null,"founded":2023,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"biotechnology","investors":[],"lat":42.365635,"lng":-71.104002,"location":"CAMBRIDGE, MA","name":"Tinos Therapeutics, Inc.","rounds":[{"amountQuarantined":false,"amountUsd":2300000,"currency":"USD","date":"2025-09-04","investors":[],"leadInvestor":null,"source":{"fact":"round","publisher":"sec-edgar","retrievedAt":"2026-05-08","status":"attributed","url":null},"status":"attributed","type":null,"url":null}],"slug":"tinostherapeutics-com","sources":[{"fact":"round","publisher":"sec-edgar","retrievedAt":"2026-05-08","status":"attributed","url":null},{"fact":"existence","publisher":"tinostherapeutics.com","retrievedAt":"2026-05-08","status":"self-reported","url":"https://tinostherapeutics.com"},{"fact":"description","publisher":"tinostherapeutics.com","retrievedAt":"2026-05-08","status":"self-reported","url":"https://tinostherapeutics.com"}],"stage":null,"techStack":["Afterpay","Squarespace","Squarespace Commerce","moment 0","lodash .","React"],"totalRaisedUsd":2300000,"updatedAt":"2026-05-08"}